Literature DB >> 24762228

Stromal cell-derived factor-1 (SDF-1)/CXCR4 axis enhances cellular invasion in ovarian carcinoma cells via integrin β1 and β3 expressions.

Yuecheng Yu1, Xiaoyan Shi, Zhen Shu, Tingting Xie, Kan Huang, Li Wei, Hui Song, Wei Zhang, Xiaochang Xue.   

Abstract

Accumulating evidence has showed that stromal cell-derived factor-1 (SDF-1/CXCR4 axis played important roles in cancer metastases, but the detailed function in ovarian cancer is still largely unknown. In the present study, we determined the location of CXCR4 and lipid rafts, a specialized structure on cell membrane, in ovarian cancer tissues and ovarian cancer cell line SKOV3 cells by immunofluorescence. To analyze the role of SDF-1/CXCR4 and lipid rafts in tumor cell migration and invasion, Transwell assay and wound healing assay were also performed. Cytoflowmetry was carried out to determine the participation of integrins. Our data showed that CXCR4 and GM1 (marker of lipid rafts) were expressed in both ovarian cancer tissue and SKOV3 cells, and SDF-1 promoted the invasion and migration of SKOV3 cells, which was mediated by complete lipid rafts. Further studies uncovered that SDF-1 upregulated the expression of integrin β1 and β3, two molecules closely related with cancer metastasis. These results indicated that SDF-1 might promote the invasion and metastasis of ovarian cancer by regulating these two integrin molecules.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24762228     DOI: 10.3727/096504014X13907540404879

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  7 in total

Review 1.  CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.

Authors:  F Guo; Y Wang; J Liu; S C Mok; F Xue; W Zhang
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

2.  The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.

Authors:  E Shinderman-Maman; K Cohen; C Weingarten; D Nabriski; O Twito; L Baraf; A Hercbergs; P J Davis; H Werner; M Ellis; O Ashur-Fabian
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

3.  Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.

Authors:  Masakazu Katsura; Fumihiro Shoji; Tatsuro Okamoto; Shinichiro Shimamatsu; Fumihiko Hirai; Gouji Toyokawa; Yosuke Morodomi; Tetsuzo Tagawa; Yoshinao Oda; Yoshihiko Maehara
Journal:  Cancer Sci       Date:  2017-11-09       Impact factor: 6.716

4.  miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway.

Authors:  Lin He; Li Zhang; Mengfei Wang; Wenrong Wang
Journal:  Exp Ther Med       Date:  2017-02-10       Impact factor: 2.447

Review 5.  Engineering CAR-T Cells for Improved Function Against Solid Tumors.

Authors:  Michael A Morgan; Axel Schambach
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

Review 6.  Bone Marrow-Derived Cells in Endometrial Cancer Pathogenesis: Insights from Breast Cancer.

Authors:  Alejandra I Ferrer; Ella Einstein; Sara S Morelli
Journal:  Cells       Date:  2022-02-17       Impact factor: 6.600

Review 7.  Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.

Authors:  Ana Cavaco; Maryam Rezaei; Stephan Niland; Johannes A Eble
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.